跳至主要内容
临床试验/ISRCTN72676102
ISRCTN72676102
已完成
不适用

Dutch randomised trial comparing standard catheter-directed thrombolysis versus ultrasound-accelerated thrombolysis for thromboembolic infra-inguinal disease (DUET)

St Antonius Hospital Nieuwegein (Netherlands)0 个研究点目标入组 60 人2009年12月8日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
未指定
发起方
St Antonius Hospital Nieuwegein (Netherlands)
入组人数
60
状态
已完成
最后更新
11年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2009年12月8日
结束日期
待定
最后更新
11年前
研究类型
Interventional
性别
All

研究者

发起方
St Antonius Hospital Nieuwegein (Netherlands)

入排标准

入选标准

  • 1\. Both males and females, greater than 18 years and less than 85 years old
  • 2\. Patients with recently (between 1 and 7 weeks) thrombosed femoro\-popliteal or femoro\-crural native arteries or femoro\-popliteal or femoro\-crural venous or prosthetic bypass grafts with ischaemic complaints
  • 3\. Patients with acute lower limb ischaemia class I and IIa according to the Rutherford classification
  • 4\. Patients understand the nature of the procedure and provide written informed consent, prior to enrolment in the study

排除标准

  • 1\. Patients with isolated common femoral artery thrombosis including the origin of the superficial femoral artery and profunda femoral artery
  • 2\. Patients with localised (less than 5 cm) emboli/occlusions in the native femoro\-popliteal arteries
  • 3\. Patients with clinical complaints of acute lower limb ischaemia due to thrombosis of the femoro\-popliteal or femoro\-crural native arteries or femoro\-popliteal or femoro\-crural venous or prosthetic bypass grafts less than 1 week and greater than 7 weeks
  • 4\. Patients with acute lower limb ischaemia class IIb and III according to the Rutherford classification
  • 5\. Patients for whom antiplatelet therapy, anticoagulants or thrombolytic drugs are contra\-indicated
  • 6\. Recent (less than 6 weeks) ischaemic stroke or cerebral bleeding
  • 7\. Patients with recent (less than 6 weeks) surgery
  • 8\. Severe hypertension (diastolic blood pressure greater than 110 mmHg, systolic blood pressure greater than 200 mmHg)
  • 9\. Current malignancy
  • 10\. Patients with a history of prior life\-threatening contrast medium reaction

结局指标

主要结局

未指定

相似试验